Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Certified by Founder
Lodge
Iterative Scopes
start up
United States
- Cambridge, Massachusetts
- 19/01/2022
- Series B
- $150,000,000
Iterative Scopes is fast becoming the leader in computational gastroenterology by pioneering the application of powerful, proprietary artificial intelligence tools to the practice of gastroenterology and drug development. Using multi-modal datasets obtained through exclusive partnerships and research collaborations, the company is aggregating the leading training data repository, forming the foundation of its software algorithms. This software fits seamlessly into existing clinical workflows to support physician decision making and clinical trial acceleration. Iterative Scopes is based in Cambridge, Massachusetts and was spun out of MIT in 2017.
- Industry Software Development
- Website https://www.iterativescopes.com/
- LinkedIn https://www.linkedin.com/company/iterative-scopes/about/
Related People
Jonathan NgFounder
United States -
Cambridge, Massachusetts
CEO of Iterative Scopes | Computational Gastroenterology for a better world.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
KeySavvy | $4,250,000 | (Nov 22, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)